Company: ACBM
Filing Date: 2025-07-11
Form Type: 10-Q
Source: 0001640334-25-001169
Chunk: 15

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-11
Form: 10-Q
Item: Item 1
Chunk 15
---
ACRO BIOMEDICAL CO., LTD.

Balance Sheets

(Unaudited)

  September 30,  December 31,   2023  2022        ASSETS      Current Assets      Cash $3,271  $5,852 Accounts receivable  -   638,500 Purchase deposit for inventory  -   12,000 Prepaid expenses  5,000   1,185 Security deposit  4,230   - Total Current Assets  12,501   657,537          Operating lease right of use asset  6,526   25,719 Security deposit  -   4,230 TOTAL ASSETS $19,027  $687,486          LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)                 Current Liabilities        Accounts payable and accrued expenses $153,036  $76,571 Deferred revenue  20,000   20,000 Due to related parties  79,078   78,826 Operating lease liabilities - current  6,526   25,719 Total Current Liabilities 258,640  201,116          TOTAL LIABILITIES  258,640   201,116          Stockholders' Equity (Deficit)        Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding  -   - Common stock: 100,000,000 authorized; $0.001 par value; 60,042,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022  60,042   60,042 Additional paid-in capital  32,297,603   32,295,236 Deferred stock compensation  -   (8,060,983)Accumulated deficit  (32,597,258)  (23,807,925)Total Stockholders’ Equity (Deficit)  (239,613)  486,370          TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $19,027  $687,486 

The accompanying notes are an integral part of these unaudited financial